ROCK2 and hilar cholangiocarcinoma: Notably, high ROCK2 expression levels were associated with poor prognoses in patients with iCCA, perihilar Cholangiocarcinoma (pCCA), and distal Cholangiocarcinoma (dCCA) (Fig. 1J–M).